U.S. Markets closed

Amneal Pharmaceuticals, LLC -- Moody's rates Amneal's new term loan B1; outlook revised to positive

Moody's Investors Service, ("Moody's") rated Amneal Pharmaceuticals, LLC's ("Amneal") proposed $2.7 billion senior secured term loan B1. Moody's also affirmed Amneal's current ratings ...